| Code | 98901 | ||||||||||
| MA number | 64/0173/06-S | ||||||||||
| Product Form: | int osd 30x0,4 ml/2 mg (obal LDPE jednod.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | AbbVie s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 18 | ||||||||||
| Container: | LDPE single-dose container | ||||||||||
| Route of admin.: | Ocular use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 20.04.2006 |
| PIL: |
PIL_Cellufluid_10.2022.pdf
|
| SPC: |
SPC_Cellufluid_10.2022.pdf
|
| Safety feature | No |
| Data update: | 18.10.2022 |
